HRT Financial’s Gilead Sciences GILD Stock Holding History

HRT Financial’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.54M	Sell	61,300 -31,200	-34%	-$4.37M	0.02%	692
2025 Q4	$11.4M	Buy	+92,500	New	+$11.2M	0.04%	411
2025 Q3	–	Sell	-27,700	Closed	-$3.07M	–	3155
2025 Q2	$3.07M	Buy	+27,700	New	+$2.95M	0.01%	741
2025 Q1	–	Sell	-8,300	Closed	-$766K	–	2827
2024 Q4	$766K	Buy	+8,300	New	+$747K	﹤0.01%	1223
2024 Q1	–	Sell	-3,200	Closed	-$259K	–	2585
2023 Q4	$259K	Buy	+3,200	New	+$249K	﹤0.01%	1683
2023 Q1	–	Sell	-3,500	Closed	-$300K	–	2741
2022 Q4	$300K	Buy	+3,500	New	+$277K	﹤0.01%	1727
2022 Q3	–	Sell	-6,900	Closed	-$426K	–	3058
2022 Q2	$426K	Sell	6,900 -12,000	-63%	-$743K	﹤0.01%	1787
2022 Q1	$1.12M	Sell	18,900 -4,400	-19%	-$281K	0.01%	944
2021 Q4	$1.69M	Buy	23,300 +9,200	+65%	+$634K	0.01%	756
2021 Q3	$984K	Buy	+14,100	New	+$991K	0.01%	1342
2020 Q4	–	Sell	-10,900	Closed	-$688K	–	2074
2020 Q3	$688K	Buy	+10,900	New	+$756K	0.02%	736
2020 Q2	–	Sell	-7,500	Closed	-$560K	–	1616
2020 Q1	$560K	Buy	+7,500	New	+$518K	0.04%	362

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HRT Financial's GILD Position: Q1 2026 in Review

HRT Financial opened a new position in Gilead Sciences (GILD) in Q1 2026: 270,699 shares worth $37.7M. The stake represents 0.09% of the portfolio and ranks #179 among its holdings. This is a return to the name: HRT Financial previously reported a position in GILD as recently as Q3 2025.

HRT Financial first reported a position in GILD in Q3 2015 and has held it in 14 quarters since. The position peaked at $147M in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

HRT Financial held 270,699 shares of Gilead Sciences worth $37.7M as of Q1 2026.
Gilead Sciences was a new HRT Financial position in Q1 2026.
Gilead Sciences made up 0.09% of HRT Financial's portfolio in Q1 2026, its #179 holding.
HRT Financial first reported a position in Gilead Sciences in Q3 2015 and has held it in 14 quarters since.
HRT Financial's Gilead Sciences position peaked at $147M in Q1 2025.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.